James Investment Research’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

James Investment Research’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Sell	56,334 -2,101	-4%	-$50.8K	0.14%	147
2026 Q1	$1.42M	Sell	58,435 -1,993	-3%	-$48.4K	0.16%	134
2025 Q4	$1.47M	Buy	60,428 +241	+0.4%	+$5.86K	0.16%	123
2025 Q3	$1.46M	Sell	60,187 -2,656	-4%	-$64.4K	0.16%	125
2025 Q2	$1.53M	Sell	62,843 -1,068	-2%	-$25.8K	0.18%	119
2025 Q1	$1.55M	Buy	63,911 +17,643	+38%	+$424K	0.2%	114
2024 Q4	$1.11M	Sell	46,268 -110	-0.2%	-$2.65K	0.13%	137
2024 Q3	$1.13M	Sell	46,378 -3,441	-7%	-$82.9K	0.13%	148
2024 Q2	$1.18M	Buy	49,819 +38,719	+349%	+$916K	0.14%	136
2024 Q1	$264K	Buy	+11,100	New	+$264K	0.03%	272

Other funds holding IBDS

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.61B AUM 26.11% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

James Investment Research's IBDS Position: Q2 2026 in Review

James Investment Research reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 3.6% in Q2 2026, selling an estimated $50.8K and leaving 56,334 shares worth $1.36M. The position accounts for 0.14% of the portfolio, ranked #147.

James Investment Research first reported a position in IBDS in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.55M in Q1 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

James Investment Research held 56,334 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $1.36M as of Q2 2026.
James Investment Research sold 2,101 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $50.8K.
iShares iBonds Dec 2027 Term Corporate ETF made up 0.14% of James Investment Research's portfolio in Q2 2026, its #147 holding.
James Investment Research first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
James Investment Research's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $1.55M in Q1 2025.
416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.